comparemela.com

Page 7 - Rafael Holdings Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc Providing for $5 0 Million of Additional Funding Via a Private Placement

Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today. | June 5, 2023

United statesWilliam conklingRafael holdings incRafael pharmaceuticals incCompany trappsolRafael holdingsCornerstone pharmaceuticals incCyclo therapeutics incCyclo therapeuticsNasdaq listing rulesChief executive officerCyclo therapeuticSecurities actCornerstone pharmaceuticalsExpanded accessNc stock exchange

Rafael : On June 1, 2023, Rafael Holdings, Inc (the Company ) entered into a Securities Purchase Agreement (the Purchase Agreement ) with Cyclo Therapeutics, Inc , a Nevada corporation ( Cyclo ) Pursuant to the Purchase Agreement, the Company will purchase 4,000,000 shares of common stock (the Shares ), and a warrant to purchase an additional 4,000,000 Shares (the Warrant ), for an aggregate purchase price of $5,000,000 The Warrant has an ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT . | June 5, 2023

United statesNew jerseyWilliam conklingNew york stock exchangeYork stock exchangeRafael holdings incCyclo therapeutics incNasdaq stock market incSecurities exchangeExchange commissionCommission file numberSecurities exchange actZip codeGeneral instructionSecurities actExchange act

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc Providing

GAINESVILLE, Fla. (BUSINESS WIRE) Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it has entere.

United statesWilliam conklingJenene thomasRafael holdingsExchange commissionCornerstone pharmaceuticals incRafael pharmaceuticals incRafael holdings incCompany trappsolCyclo therapeutics incCyclo therapeuticsNasdaq listing rulesChief executive officerCyclo therapeuticSecurities actCornerstone pharmaceuticals

Rafael (NYSE:RFL) Stock Price Up 1 6%

Rafael Holdings, Inc. (NYSE:RFL – Get Rating)’s stock price traded up 1.6% during mid-day trading on Monday . The stock traded as high as $1.95 and last traded at $1.93. 8,592 shares changed hands during trading, a decline of 86% from the average session volume of 59,963 shares. The stock had previously closed at $1.90. […]

Rafael pharmaceuticalsSusquehanna international groupRenaissance technologiesRafael holdings incCharles schwab investment management incLipomedix pharmaceuticalsGeode capital managementRafael holdingsGet ratingCapital managementInternational groupCharles schwab investment managementReal estateRafael daily

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Company on track to complete enrollment in ongoing pivotal Phase 3 global study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 by year end 2023 . | May 15, 2023

United statesWilliam conklingRafael holdings incCompany boardCompany trappsolCompany phaseRafael holdingsCyclo therapeutics incCyclo therapeuticsChief executive officerFinancial resultsFirst quarterExpanded accessNc stock exchangePress releaseNd rfl us75062e1064

vimarsana © 2020. All Rights Reserved.